{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:24:15Z","timestamp":1781097855463,"version":"3.54.1"},"reference-count":38,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Switching from efavirenz (EFV) to dolutegravir (DTG) is increasingly common due to DTG's superior efficacy and tolerability, yet its metabolic impact in Southeast Asian populations remains unclear. We conducted a single-center retrospective cohort study (January 2019\u2013December 2022) involving adults on EFV-based antiretroviral therapy for at least 6 months before transitioning to DTG. Weight, body mass index, lipid profiles, fasting blood glucose (FBG), renal function, and alanine transaminase (ALT) were measured at baseline, Month 6, and Month 12. Among 493 participants (mean age 47.6 years; 69% female), mean weight increased from 63.8 to 65.6\u2005kg at Month 12 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.001). TC, low-density lipoprotein cholesterol (LDL-C), and triglycerides decreased, while high-density lipoprotein cholesterol (HDL-C) declined and FBG modestly improved. Estimated glomerular filtration rate (eGFR) dropped by 25% (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.001). Higher baseline HDL-C was protective against significant weight gain (OR 0.11 per 10\u2005mg\/dL,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u2009.030). EFV-to-DTG switching leads to weight gain, mixed metabolic effects, and notable eGFR decline, supporting regular monitoring.\n                  <\/jats:p>","DOI":"10.1177\/23259582261432459","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:38:58Z","timestamp":1773236338000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes in Metabolic Parameters After Switching From Efavirenz to Dolutegravir-Based Regimen: A Cohort Study in Thai People Living With HIV"],"prefix":"10.1177","volume":"25","author":[{"given":"Pitchaporn","family":"Chongyangyuenvong","sequence":"first","affiliation":[{"name":"Mahidol University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-4704","authenticated-orcid":false,"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[{"name":"Mahidol University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0400-5"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30036-9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00388-5"},{"issue":"4","key":"e_1_3_3_5_2","first-page":"407","article-title":"HIV And cardiovascular disease: From insights to interventions","volume":"29","author":"Feinstein MJ","year":"2021","unstructured":"Feinstein MJ. HIV And cardiovascular disease: From insights to interventions. Top Antivir Med. 2021;29(4):407-411. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8670825\/ (accessed Nov 29, 2025)","journal-title":"Top Antivir Med"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32833ed7ec"},{"key":"e_1_3_3_7_2","unstructured":"Thailand National Guidelines on HIV\/AIDS Treatment and Prevention 2021\/2022. Accessed Jan 17 2025. https:\/\/www.thaiaidssociety.org\/thailand-hiv-aids-guideline\/"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S84850"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100573"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000616"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101836"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.4102\/sajhivmed.v24i1.1500"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904340"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902824"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0266-2"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.086348"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2717-x"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0266-2"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/09564624221129410"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-03008-7"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61717-7"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2023.102807"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1073"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08892-8"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV17025"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X221079444"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61853-4"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215541"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu051"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx365"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0098-2997(02)00090-0"},{"key":"e_1_3_3_32_2","unstructured":"World Health Organization. Update of recommendations on first- and second-line antiretroviral regimens 2019. Accessed Jan 19 2025. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-19.15"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04440.x"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.115.067694"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2019.02.006"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw064"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.16009"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl524"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae170"}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582261432459","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23259582261432459","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582261432459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:50:57Z","timestamp":1777503057000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23259582261432459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["10.1177\/23259582261432459"],"URL":"https:\/\/doi.org\/10.1177\/23259582261432459","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"23259582261432459"}}